Tectonic Therapeutic, Inc.

Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit https://tectonictx.com/ and follow us on LinkedIn.

Current securities

1. 10-Q filingAug 6, 2026
2. Results of Operations and Financial ConditionAug 6, 2026
3. Submission of Matters to a Vote of Security Holders · Other EventsJun 10, 2026
4. 4 filingJun 10, 2026
5. 4 filingJun 10, 2026